Complications associated with the use of central venous access devices

Current Problems in Surgery

Volumn 33, Issue 4, 1996, Pages 309-378

  Whitman, Eric D ^a,b  

^a Section of Endocrine and Oncologic Surgery

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL VENOUS CATHETERIZATION; EQUIPMENT; HUMAN; INDWELLING CATHETER; INFECTION; INSTRUMENTATION; METHODOLOGY; REVIEW; THROMBOSIS; TIME;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT FAILURE; HUMANS; PROSTHESIS-RELATED INFECTIONS; THROMBOSIS; TIME FACTORS;

EID: 0030117209     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0011-3840(96)80008-6     Document Type: Article

References (188)

1. Eroviac JW, Cole I), Schribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973:136:602-6.
2. Hickman RO, Buckner CD, Clift RA. Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow t-ansplant recipients. Surg Cynecol Obstet 1979;148:871-5.
3. Miederhuhor JE, Knsminger W, Gyvos JW, Lipeman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982:92:706-12.
4. Mansfield PE Holm DC, Fornage BD, Gregurich MA, Ota DM. Complications and failures of subclavian-vein catheteri/ation. N Engl J Mod 1994;331:1735-8.
5. Kolff WJ. The first clinical experience with the artificial kidney. Ann Intern Mod 1965:62:608-15.
6. Quinton WE. Dillard D, Scribner BH. Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 1960:6:104-8.
7. Brescia MJ, Cimino JE, Appel K, Hurwich BJ. Chronic hemodialysis using \enipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966:275:1089-92.
8. Giacchino JL, Geis WP, Buckingham JM, Vertuno LL, Bansal VK. Vascular tccess: long-term results, new techniques. Arch Surg 1979:114:403-9.
9. Raaf JH. Results from use of 826 vascular access devices in cancer patients. Cancer 1985:55:1312-21.
10. Pruitt BA, Stein JM. Foley FD, Moncrief JA, O'Neill JA. Intravenous therapy in burn patients. Arch Surg 1970;100:399-403.
11. Priedman BA, Jurgeleit HC. Perforation of atrium by polyethylene CV catheter. JAMA 1968:203:139-40.
12. Krog M. Berggren L. Brodin M, Wickbom G. Pericardial tamponade caused by central venous catheters. World J Surg 1982:6:138-43.
13. Dudrick SJ, Wilmore DW, Yars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968;64:134-42.
14. Whitman ED. A critical evaluation of valved central venous catheters. Journal of Vascular Access Devices 1995;1:11-2.
15. Whitman ED, Kuppel LJ. Safe effective strategy for subclavian venous access in severely thrombocytopenic cancer patients [abstract]. Proceedings of American Society of Clinical Oncology 1994:1679.
16. Haire WD, Lynch TG, Lieberman RP, Edney JA. Duplex scans before subclavian vein catheterization predict unsuccessful catheter placement. Arch Surg 1992;127:229-30.
17. Bay WH. Correlation of color flow Doppler and angiography. In: Henry ML, Ferguson RM, eds. Vascular access for hemodialysis. III. Hong Kong: Precept Press, Inc, 1993:95-101.
18. Robertson LJ, Mauro MA, Jaques PE Radiologie placement of Hickman catheters. Radiology 1989;!70:1007-9.
19. Pearl JM, Goldstein L, Ciresi KF. Improved methods in long-term venous access using the PAS Port. Surg Gynecol Obstet 1991;173:313-5.
20. Goldfarb PM, Coldwell D. Chronic venous access: bedside placement technique and complications. Cancer Pract 1994;2:279-83.
21. Ault MJ. Low infection rate and long durabiltity of nontunneled silastic catheters [Letter]. Arch Intern Med 1994;154:1041.
22. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunnelled silastic catheters: a safe and cost-effective alternative for longterm venous access. Arch Intern Med 1993;153:1791-6.
23. Bottino J, McCredie KB, Groschel DHM, Lawson M. Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases. Cancer 1979;43:1937-43.
24. Kirkemo A, Johnston MR. Percutaneous subclavian vein placement of the Hickman catheter. Am J Surg 1982;91:349-51.
25. Fuel V, Caudry M, LeMetayer P, et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 1993;72:2248-52.
26. Gould JR, Carloss HW, Skinner WL. Groshong catheter-associated subclavian venous thrombosis. Am J Med 1993;95:419-23.
27. Morton JE, Jan-Mohamed RMI, Barker HF, Milligan DW. Percutaneous insertion of subclavian Hickman catheters. Bone Marrow Transplant 1991;7:39-41.
28. Gualitieri E, Deppe SA, Sipperly ME, Thompson DR. Subclavian venous catheterization: greater success rate for less experienced operators using ultrasound guidance. Grit Care Med 1995;23:692-7.
29. Loughran SC, Borzatta M. Peripherally inserted central catheters: a report of 2506 catheter days. JPEN J Parenter Enterai Nutr 1995;19:133-6.
30. Cardella JF, Fox PS, Lawler JB. Interventional radiologie placement of peripherally inserted central catheters. J Vase Intervent Radiol 1993;2:65360.
31. Bleacher JC, Yang HC. A technique for proper positioning of Hickman and Port-A-Cath catheters. Am Surg 1993;59:453-4.
32. Huffman MA, Langer JC, Pearl RH, et al. Central venous catheters: no xrays needed: a prospective study in 50 consecutive infants and children. J Pediatr Surg 1988;23:1201-3.
33. Dierks MM, Whitman ED. Catheter tip position in the analysis of central venous access device outcome. Journal of Vascular Access Devices (in press).
34. Lund GB, Lieberman RR Haire WD, Martin VA, Kessinger A, Armitage JO. Translumber inferior vena cava catheters for long-term venous access. Radiology 1990:174:31-5.
35. Haire WD, Lieberman RR Lund GB, Kessinger A. Translumbar inferior vena cava catheters. Bone Marrow Transplant 1991;7:389-92.
36. Treiman GS, Siberman H. Chronic venous access in patients with cancer. Cancer 1993:72:760-5.
37. Lazarus HM, Creger RJ, Bloom AD, Shenk R. Percutaneous placement of femoral central venous catheter in patients undergoing transplantation of bone marrow. Surgery 1990:170:403-6.
38. Getzen LC, Pollak EW. Short-term femoral vein catheterization. Am J Surg 1979:138:875-8.
39. Williams JF, Seneff MG, Friedman BC, et al. Use of femoral venous catheters in critically ill adults: prospective study. Grit Care Med 1991:19:550-3.
40. T'ottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Grit Care Med 1995:23:52-8.
41. Harden JL, Kemp L, Mirtallo J. Femoral catheters increase risk of infection in total parenteral nutrition patients. Nutr Clin Pract 1995:10:60-6.
42. Barrios CH, Zuke JE, Blaes B, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Cncology 1992:49:474-8.
43. Brothers TE, Von Moll LK, Niederhuber JE, Roberts JA, Walker-Andrews S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988:166:295-301.
44. Carde R Cosset-Delaigue MF, LaPlanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989:25:939-44.
45. Slater H, Goldfarb IW, Jacob HE, Hill JB, Srodes CH. Experience with longterm outpatient venous access utilizing percutaneously placed silicone elastomer catheters. Cancer 1985:56:2074-7.
46. Eroadwater JR, Henderson MA, Bell JL, et al. Outpatient percutaneous csntral venous access in cancer patients. Am f Surg 1990:160:676-80.
47. F:>ster PF, Moore LR, Sankary HN, Hart ME. Ashmann MK, Williams JW. Central venous catheterization in patients with coagulopathy. Arch Surg 1992:127:273-5.
48. Liefalque RJ, Campbell C. Cardiac tamponade from central venous catheters. Anesthesiology 1979;50:249-52.
49. E His LM, Vogel SB, Copeland EM. Central venous catheter vascular erosions: diagnosis and clinical course. Ann Surg 1989:209:475-8.
50. Henzel JH, DeWeese MS. Morbid and mortal complications associated with prolonged central venous cannulation. Am J Surg 1971;121:600-5.
51. Sheep RE, Guiney WB. Fatal cardiac tamponade: occurrence with other complications after left internal jugular vein catheterization. JAMA 1982;248:1632-5.
52. McGee WT, Ackerman BL, Rouben LR, Prasad VM, Bandi V, Mallory DL. Accurate placement of central venous catheters: a prospective, randomized, riulticenter trial. Grit Care Med 1993:21:1118-23.
53. Geis WR Johnson CF, Zajtchuk R, Kittle CE Extrapericardial (mediastinal) cardiac tamponade. Arch Surg 1970;100:305-6.
54. Collier PE, Ryan JJ, Diamond DL. Cardiac tamponade from central venous catheters report of a case and review of the English literature. Angiology 1984;35:595-600.
55. Dimitrious V, O'Leary AM. Perforation of the trachea by a central venous catheter guidewire. Can J Anaesth 1994;40:903-4.
56. Vanherweghem J, Cabolet P. Dhaene M, et al. Complications related to subclavian catheters for hemodialysis. Am J Nephrol 1986;6:339-45.
57. Karnauchow PN. Cardiac tamponade from central venous catheterization. Can Med Assoc J 1986;135:1145-7.
58. Scott WL. Complications associated with central venous catheters: a survey. Chest 1988:94:1221-4.
59. The Food and Drug Administration Task Force. Precautions necessary with central venous catheters. PDA Drug Bulletin 1989;15-6.
60. Wiener ES, McGuire P Stolar CJH, et al. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg 1992;27:155-64.
61. Petersen FB, Clift RA, Hickman RO, et al. Hickman catheter complications in marrow transplant recipients. JPEN J Parenter Enterai Nutr 1986;10:5862.
62. Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168-74.
63. Hiemenz J, Skelton J, Pizzo PA. Perspective on the management of catheterrelated infections in cancer patients. Pediatr Infect Dis 1986;5:6-11.
64. Cameron GS. Central venous catheters for children with malignant disease: surgical issues. J Pediatr Surg 1987;22:702-4.
65. Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156-62.
66. Mueller BU, Skelton J, Callender DPE, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-8.
67. Mirro J Jr, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 1990:25:120-4.
68. Whitman ED, Boatman AM. Comparison of diagnostic specimens and methods to evaluate infected venous access ports. Am J Surg 1995:170:665-70.
69. Press OW, Ramsey PG, Larsori EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine 1984:63:189-200.
70. Schuman ES, Winters V, Gross GF, Hayes JF. Management of Hickman catheter sepsis. Am J Surg 1985:149:627-8.
71. Raucher HS, Hyatt AC, Barzilai A, et al. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters. J Pediatr 1984:104:29-33.
72. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987:6:729-34.
73. Wing EJ, Norden CW, Shadduck RK, Winkelstein A. Use of quantitative bactériologie techniques to diagnose catheter-related sepsis. Arch Intern Med 1979:139:482-3.
74. Christensen G, Simpson W, Bisno A, Beachey E. Adherence of slimeproducing strains of staphylococcus epidermis to smooth surfaces. Infect Immun 1982:37:318-26.
75. Wang EEL, Prober CG, Ford-Jones L, Gold R. The management of central intravenous catheter infections. Pediatr Infect Dis 1984;3:110-3.
76. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infections. N Engl J Med 1977;296:1305-9.
77. Bol he A, Piccione W, Ambrosino JJ, Benotti PN, Lokich JJ. Implantable central venous access system. Am J Surg 1984;147:565-9.
78. Lawson M. Partial occlusion of indwelling central venous catheters. J Intraven Nurs 1991;14:157-9.
79. Deuwarte J. Experience with residue in the reservoirs of implanted ports. Journal of Vascular Access Networks 1993;3:16-8.
80. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunneled central venous catheters. Cancer 1995;75:1367-75.
81. Jones GR, Konsler GK, Dunaway RP, Lacey SR, Azizkhan G. Prospective analysis of urokinase in the treatment of catheter sepsis in pédiatrie hematology-oncology patients. J Pediatr Surg 1993;28:350-7.
82. As±er DP, Shoupe BA, Maybee D, Fischer GW. Persistent catheter-related baoteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993;28:627-9.
83. Fishbein JD, Friedman HS, Bennet BB, Falletta JM. Catheter-related sepsis refractory to antibiotics treated successfully with adjunctive urokinase iniusion. Pediatr Infect Dis J 1990;9:676-8.
84. LaQuaglia MP, Caldwell C, Lucas AB, et al. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hiakman catheter sepsis in children. J Pediatr Surg 1994;29:742-5.
85. Jolmson DC, Johnson FL, Goldman S. Preliminary results treating persistent ceitral venous catheter infections with the antibiotic lock technique in pédiatrie patients. Pediatr Infect Dis J 1994;!3:930-1.
86. Al-Sibai MB, Harder EJ, Faskin RW, Johnson GW, Padmos MA. The value of prophylactic antibiotics during the insertion of long-term indwelling silastic right atrial catheters in cancer patients. Cancer 1987;60:1891-5.
87. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Doublebl nd placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990;15:95-102.
88. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia. Arch Intern Med 1995;155:1161-6.
89. Benerjee C, Bustamante CI, Wharton R, Talley E, Wade JC. Bacillus infections in patients with cancer. Arch Intern Med 1988;148:1769-74.
90. Blue SR, Singh VR, Saubolle MA. Bacillus licheniformis bacteremia: five cases associated with indwelling central venous catheters. Clin Infect Dis 1995:20:629-33.
91. Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989:8:99-104.
92. Locciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: analysis of 155 episodes. Clin Infect Dis l992;14:875-83.
93. Geoeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation oi the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993:218:206-10.
94. Keohane PP Attrill H, Northover J, et al. Effect of catheter tunneling and a nutrition nurse on catheter sepsis during parenteral nutrition: a controlled trial. Lancet 1983;1:1388-90.
95. O'Keefe SJD, Burnes JU, Thompson RL. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors. JPEN J Parenter Enterai Nutr 1994;18:256-63.
96. Christensen ML, Hancock ML, Gattuso J, et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer 1993;72:2732-8.
97. Phillips G, Slingluff C, Hartman J, Thomas P Akwari O. Totally implantable intravenous catheters in the management of sickle cell anemia. Am J Hematol 1988;29:134-8.
98. Raviglione MC, Battan R, Pablos-Mendez A, Aceves-Casillas P, Müllen MR Taranta A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989;86:780-6.
99. Early TF, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990;83:34-6.
100. Wagman LD, Kirkemo A, Johnston MR. Venous access: a prospective, randomized study of the Hickman catheter. Surgery 1984;95:303-8.
101. Andrivet P, Bacquer A, Ngoc C V, et al. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis 1994;18:199-206.
102. MirroJ Jr, Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pédiatrie oncology patients. J Clin Oncol 1989;7:214-22.
103. Stanislav GV, Fitzgibbons RJ Jr, Bailey RT Jr, Mailliard JA, Johnson S, Feole JB. Reliability of implantable central venous access devices in patients with cancer. Arch Surg 1987;122:1280-3.
104. Ross MN, Haase GM, Poole MA, Burrington JD, Odom LE Comparison of totally implanted reservoirs with external catheters as venous access devices in pédiatrie oncologic patients. Surg Gynecol Obstet 1988;167:141-4.
105. McCready D, Broadwater R, Ross M, Pollock R, Ota D, Balch C. A casecontrol comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients. J Surg Res 1991;51:377-81.
106. Vassilomanolakis M, Plataniotis G, Koumakis G, et al. Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis. Bone Marrow Transplant 1995;15:77-80.
107. Lim SH, Smith MP Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. Eur J Haematol 1993;51:10-3.
108. Greenfield J, Sampath L, Popilskis S, Brunnert S, Stylianos S, Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Grit Care Med 1995;23:894-900.
109. Jansen B, Goodman L, Ruiten D. Bacterial adherence to hydrophilic polymercoated polyurethane stents. Gastroint Endosc 1993;39:670-3.
110. Maki DG, Cobb L, Carman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospecive randomized multicenter trial. Am J Med 1988;85:307-14.
111. Fraschini G. Urokinase prophylaxis of central venous ports reduces infections and thrombotic complications [abstract]. NAVAN Fifth Annual Conference Syllabus 1991:33.
112. Anderson AJ, Krasnow SH, Boyer MW, étal. Thrombosis: the major Hickman ca'.heter complication in patients with solid tumor. Chest 1989:95:71-5.
113. Home III MK, May DJ, Alexander HR, et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann Surg Oncol 1995;2:174-8.
114. Haire WD, Lieberman RP, Edney J, et al. Hickman catheter-induced thoracic vein thrombosis: frequency and long-term sequelae in patients receiving hi;:>h-dose chemotherapy and marrow transplantation. Cancer 1990:66:900-8.
115. Haire WD, Lieberman RP, Lund GB, Edney JA, Kessinger A, Armitage JO. Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Croshong catheters. Bone Marrow Transplant 1991:7:57-9.
116. BtrnMM, LokichJJ, Wallach SR, etal. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990:112:423-8.
117. Didisheim R Current concepts of thrombosis and infection in artificial organs. ASAIO J 1993;40:230-4.
118. EcStridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13:233-8.
119. Pithie A, Soutar JS, Pennington CR. Catheter tip position in central vein thrombosis. JPEN I Parenter Enterai Nutr 1988;12:613-4.
120. Welch GW, McKeel DW, Silverstein P, Walker HL. The role of catheter composition in the development of thrombophlebitis. Surg Gynecol Obstet 1974;138:421-4.
121. Fabri PJ, Mirtallo JM, Ebbert ML, Kudsk KA, Powell C, Ruberg RL. Clinical effect of nonthrombotic total parenteral nutrition catheters. JPEN J Parenter Enterai Nutr 1984:8:705-7.
122. Appelgren P, Ransjo U, Bindslev L, Larm O. Does surface heparinisation reduce bacterial colonisation of central venous catheters? Lancet 1995:345:130.
123. Mohammad SF Association between thrombosis and infection. ASAIO J 1993:40:226-30.
124. Riad I, Luna M, Khalil SM, Costerton JW, Lam C, Bodey GR The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994:271:1014-6.
125. Hoshal VL, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 1971:102:353-7.
126. Cheung AL, Fischetti VA. The role of fibrinogen in mediating staphylococcal adherence to fibers. J Surg Res 1991:50:150-5.
127. Viudaux P, Pittet D, Haeberli A, et al. Host factors selectively increase slaphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989;160:865-75.
128. Brismar B, Hardstedt C, Jacobson S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization. Ann Surg 1981;194:779-83.
129. Ang AK, Brown OW. Septic deep vein thrombosis. J Vase Surg 1986;4:5636
130. Kerr TM, Lutter KS, Moeller DM, et al. Upper extremity venous thrombosis diagnosed by duplex scanning. Am J Surg 1990:160:202-6.
131. Karnik R, Valentin A, Winkler W, Donath P, Slany J. Duplex sonographic detection of internal jugular venous thrombosis after removal of central venous catheters. Clin Cardiol 1993;16:26-9.
132. Becker DM, Philbrick JT, Walker FB. Axillary and subclavian venous thrombosis. Arch Intern Med 1991;151:1934-43.
133. Gray BH, Olin JW, Graor RA, Young JR, Bartholomew JR, Ruschhaupt WE Safety and efficacy of thrombolytic therapy for superior vena cava syndrome. Chest 1991;99:54-9.
134. Seigel EL, Jew AC, Delcore R, Iliopoulos JI, Thomas JH. Thrombolytic therapy for catheter-related thrombosis. Am J Surg 1993;166:716-9.
135. Gibson SP, Mosquera DA, O'Donnell MJ, Odurny A. Streptokinase in the treatment of innominate-vein thrombosis in association with haemodialysis catheter: preservation of a precious arteriovenous fistula. Nephrol Dial Transplant 1991;6:206-8.
136. Barclay G, Allen K, Pennington C. Tissue plasminogen activator in the treatment of superior vena caval thrombosis associated with parenteral nutrition. Postgrad Med J 1990:66:398-400.
137. Haire WD, Lieberman RR Thrombosed central venous catheters: restoring function with 6-hour urokinase infusion after failure of bolus urokinase. JPEN J Parenter Enterai Nutr 1992;16:129-32.
138. Haire WD, Lieberman RP, Schmit-Pokorny K, Kessinger A. Urokinase infusion restores function of thrombotically-occluded inferior vena cava apheresis catheters refractory to bolus urokinase therapy. Transfus Sei 1991;12:311-6.
139. Monreal M, Lafoz E, Ruiz J, Vails R, Alastrue A. Upper-extremity deep venous thrombosis and pulmonary embolism. Chest 1991;99:280-3.
140. Leiby JM, Purcell H, DeMaria JJ, Kraut EH, Sagone AL, Metz EN. Pulmonary embolism as a result of Hickman catheter-related thrombosis. Am J Med 1989)86:228-31.
141. Anderson AJ, Krawnow SH, Boyer MW, et al. Hickman catheter clots: a common occurrence despite daily heparin flushing. Cancer Treat Rep 1987;71:651-3.
142. Lawson M, Bottino JC, Hurtubise MR, McCredie KB. The use of urokinase to restore the patency of occluded central venous catheters. American Journal of Intravenous Therapy and Clinical Nutrition 1982;Oct:29-32.
143. Shulman RJ, Reed T, Pitre D, Laine L. Use of hydrochloric acid to clear obstructed central venous catheters. JPEN J Parenter Enterai Nutr 1988;12:509-10.
144. Breaux CW, Duke D, Georgeson KE, Mestre JR. Calcium phosphate crystal occlusion of central venous catheters used for total parenteral nutrition in infants and children: prevention and treatment. J Pediatr Surg 1987;22:829-32.
145. Haire WD, Atkinson JB, Stephens LC, Kotulak GD. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blinded, randomized trial. Thromb Haemost 1994:72:543-7.
146. Home III MK, Mayo DJ, Wittes RE. Heparinized saline to flush Groshong catheters. J Clin Oncol 1993;11:2458.
147. Mayo DJ, Helsabeck CB, Home III MK. Intraluminal clots in Groshong catheters. Journal of Vascular Access Devices 1995;l:20-2.
148. Pasquale MD, Campbell JM, Magnant CM. Groshong versus Hickman catheters. Surg Gynecol Obstet 1992;174:408-10.
149. Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990:177:353-6.
150. Lafreniere R. Indwelling subclavian catheters and a visit with the "pinchedoff sign." J Surg Oncol 1991;47:261-4.
151. Akken DR, Minton JP The "pinch-off sign": a warning of impending problems with permanent subclavian catheters. Am J Surg 1984;148:633-6.
152. Andris DA, Krzywda EA, Schulte W, Ausman R, Quebbeman EJ. Pinch-off sy:idrome: a rare etiology for central venous catheter occlusion. JPEN J Parenter Enterai Nutr 1994;18:531-3.
153. Richardson JD, Grover FL, Trinkle JK. Intravenous catheter emboli: experience with twenty cases and collective review. Am J Surg 1974;128:722-7.
154. Jacobs DM, Fink AS, Miller RP, et al. Anatomical and morphological évaluation of pacemaker lead compression. PACE 1993:16:434-45.
155. Lambert ME, Chadwick GA, McMahon A, Scarffe JH. Experience with the portacath. Hematol Oncol 1987;6:57-63.
156. Bach F, Videbaek C, Holst-Christensen J, Boesby S. Cytostatic extravasation: a serious complication of long-term venous access. Cancer 1991:68:538-9.
157. Gemlo BT, Rayner AA, Swanson RJ, Young JA, Homann JF, Hohn DC. A se-ious complication of the split-sheath introducer technique for venous access. Arch Surg 1988;123:490-2.
158. Reed WP, Newman KA, Applefeld MM, Sutton FJ. Drug extravasation as a complication of venous access ports. Ann Intern Med 1985:102:788-9.
159. Schneider TC, Krzywda E, Andris D, Quebbeman EJ. The malfunctioning silastic catheter: radiologie assessment and treatment. JPEN J Parenter Enterai Nutr 1986;10:70-3.
160. Gebarski SS, Gebarski KS. Chemotherapy port "Twiddler's syndrome." Cancer 1984;54:38-9.
161. Biincker H, Saeter G. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer 1986:57:1124-9.
162. Cassidy FP, Zajko AB, Bron KM, Reilly JJ, Peitzman AB, Steed DL. Noninfectious complications of long-term central venous catheters. AJR An J Roentgenol 1987;149:671-5.
163. Müllen JL, Oleaga J, Ring EJ. Catheter migration during home hyperalimentation. JAMA 1977:238:1946-7.
164. Farrugia M, Watkinson AF, Adam A. An unusual complication of Hickman Cctheter insertion due to morbid obesity. J Intervent Radiol 1995:10:15-7.
165. Borja AR, Masri Z, Shruck L, Pejo S. Unusual and lethal complications of infraclavicular subclavian vein catheterization. Int Surg 1995:57:42-5.
166. McCarthy PM, Wang N, Birchfield F, Mehta AC. Air embolism in singlelung transplant patients after central venous catheter removal. Chest 1995:4:1178-9.
167. Flanagan JP, Gradisar IA, Gross RJ, Kelly TR. Air embolus: a lethal complication of subclavian venipuncture. N Engl J Med 1969:281:488-9.
168. Feliciano DV, Mattox KL, Graham JM, Beall AC, Jordan GL. Major complications of percutaneous subclavian vein catheters. Am J Surg 1979:138:869-74.
169. Neubauer A-R Percutaneous central IV access in the neonate: experience with 535 silastic catheters. Acta Paediatr 1995;84:756-60.
170. Szarkhammar H, Bengtsson M, Gain TB, et al. A new injection portal for brachially inserted central venous catheter: a multicenter study. Med Oncol Tumor Pharmacother 1990:7:281-5.
171. Black A, Lloyd-Thomas AR. An unusual case of stridor. Anaesthesia 1988:43:870-1.
172. Reid C, Sheridan P, Desparmet J, Adolph V. Unintended transthoracic pulmonary artery cannulation: a complication of central line insertion. Anesthesiology 1995;82:1526-8.
173. Nakayama M, Fujita S, Kavvamata M, Namiki A, Mayumi T. Traumatic aneurysm of the internal jugular vein causing vagal nerve palsy: a rare complication of percutaneous catheterization. Anesth Analg 1994;78:598-600.
174. Thurer RJ. Chylothorax: a complication of subclavian vein catheterization and parenteral hyperalimentation. J Thorac Cardiovasc Surg 1976;71:468.
175. Marelich GP, Tharratt RS. Greenfield inferior vena cava filter dislodged during central venous catheter placement. Chest 1994;106:957-9.
176. Amesbury S, Vargish T, Hall J. An unusual complication of central venous catheterization. Chest 1994;105:905-7.
177. Aldridge HE, Lee J. Transvascular removal of catheter fragments from the great vessels and heart. Can Med Assoc J 1977;117:1300-4.
178. Reed WP, Newman KA, Tenney JH. An improved technique for the removal of long-term implantable central venous lines. Surg Gynecol Obstet 1985:161:479-80.
179. Al-Wali WI, Wilcox MH, Thickett KJ, Simmons KM, Spencer RC. Retained Hickman cuff as a source of infection. J Infect 1993;26:199-201.
180. Ruppel LJ, Brown RA, Borson RA, Whitman ED. Retained Hickman catheter cuff as an infectious source following allogeneic bone marrow transplant. Bone Marrow Transplant 1994;14:169-71.
181. Cardella JE Lukens ML, Fox PS. Fibrin sheath entrapment of peripherally inserted central catheters. J Vase Intervent Radiol 1994;5:439-42.
182. Andrews JC, Walker-Andrews SC, Ensminger WD. Long-term central venous access with a peripherally placed subcutaneous infusion port: initial results. Radiology 1990;176:45-7.
183. Walker S, Calzone K. Trial results with a new peripherally placed implantable central venous access port, Bard CathLink. Journal of Vascular Access Networks 1994;1:7-11.
184. Herrmann M, Vaudaux P, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158:693-701.
185. Tenney JH, Moody MR, Newman KA, et al. Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Arch Intern Med 1986;146:1949-54.
186. Valentin-Weigand P, Timmis KN, Chhatwal GS. Role of fibronectin in staphylococcal colonisation of fibrin thrombi and plastic surfaces. J Med Microbiol 1993;38:90-5.
187. Vaudaux P, Pittet D, Haeberli A, et al. Fibronectin is more active than fibrin or fibrinogen in promoting staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 1993;167:633-41.
188. Cheung A, Fischetti V The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 1990;161:1177-86.